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Anurans are declining worldwide because of the spread of Batachochytrium
dendrobatidis (Bd), the fungus that causes chytridiomycosis. However, some frogs are
resistant to this disease, and understanding why may be critical to saving those that are
susceptible. In Peru, Gastrotheca excubitor is resistant to chytridiomycosis while
Gastrotheca nebulanastes is susceptible. Two anuran skin defenses, symbiotic bacteria
and antimicrobial peptides (AMPs), have demonstrated the ability to inhibit Bd in vitro
when isolated from certain frogs. We tested if these defenses can explain the difference
in susceptibility between the two Gastrotheca species. The cutaneous bacteria and
AMPs of both species were collected, tested for their abilities to inhibit the growth of Bd,
and analyzed for their compositions. Results indicate that 34%of the strains of skin
bacteria from G. excubitor were able to inhibit the growth of Bd whereas only 10%
isolated from G. nebulanastes were effective. Gastrotheca excubitor also has stronger
anti-Bd skin bacteria. Neither frog species has peptide mixtures capable of completely
inhibiting Bd, and overall species did not differ in the anti-Bd abilities of their peptides.
These results suggest that the chytridiomycosis resistance experienced by G. excubitor
may be attributed to its skin bacteria.
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CHAPTER 1
NATURAL ANURAN DEFENSES AGAINST CHYTRIDIOMYCOSIS: THE ROLES OF
ANTIMICROBIAL PEPTIDES AND CUTANEOUS BACTERIA
INTRODUCTION:
Amphibians are currently one of the most endangered vertebrate groups.
Approximately one third of all amphibian species are listed as threatened by the IUCN,
and in the past several decades there have been over 100 species extinctions and
thousands of populations have experienced significant declines (Stuart et al., 2004).
Many factors are contributing to amphibian declines including habitat loss, climate
change, and the spread of infectious diseases (Fisher and Shaffer, 1996, Davidson et
al., 2001, Marsh and Trenham, 2001, Pounds et al., 1997, Pounds et al., 1999,
Kiesecker et al., 2001, Carey and Alexander, 2003, Daszak et al., 2003). One of these
infectious diseases, chytridiomycosis, may be the most significant contributor to
amphibian declines.
Chytridiomycosis is caused by the fungus Batrachochytrium dendrobatidis (Bd).
It is an emerging infectious disease that has been linked to the extinctions and
extirpations of numerous amphibian species world-wide (Daszak and Berger, 1999,
Berger et al., 1998b, Skerratt et al., 2007, Fisher et al., 2009). Bd was first described
when the fungus was isolated from dead and dying frogs from Australia and Central
America (Berger et al. 1998). Effective treatment strategies for chytridiomycosis are
critical because it is unlikely that Bd will be eradicated form the environment.
Chytridiomycosis is currently treated by various anti-fungal drugs or by heat therapy.
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While both strategies are effective, none of these have any applications for frogs in situ.
A strategy that can protect the remaining vulnerable frogs may allow for populations to
persist in their natural environment.
Because some frog species are resistant to Bd, their natural defenses are being
studied for their abilities to inhibit fungal growth. Two of these defenses, antimicrobial
peptides (AMPs) and cutaneous skin bacteria, show promise. AMPs and cutaneous
bacteria from many frog species have already demonstrated anti-Bd capabilities.
Perhaps one or both of these defenses could be applied to or amplified in susceptible
frogs as an enriching defense against Bd.

ROLE OF BATRACHOCHYTRIUM DENDROBATIDIS IN AMPHIBIAN DECLINES:
Bd infects its amphibian host with motile zoospores in aqueous environments.
The zoospores infect keratinized mouthparts on tadpoles or keratinized epidermal skin
cells on adults. Following infection, the fungus grows as a thallus and eventually
produces reproductive structures, the zoosporangia, where new zoospores are
produced and released (Berger et al., 2005a, Kilpatrick et al., 2010). Infection causes
reduced electrolyte transport, impairing osmoregulation and ultimately causing death by
asystolic cardiac arrest (Voyles et al., 2009). The fungus has been shown to spread
geographically very quickly (Vredenburg et al., 2010). Once arriving in a new location,
Bd can quickly reduce the population size of the naive frog species (Lips et al., 2006).
Bd has had a global impact on amphibian populations. To date significant declines
attributed to Bd have occurred in Australia, Panama, Costa Rica, Peru, and the United
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States (Pounds et al., 1997, Berger et al., 1998b, Lips et al., 2008, Catenazzi et al.,
2011, Vredenburg et al., 2010, Vredenburg et al., 2011).

AMPHIBIAN IMMUNE SYSTEM:
To fight off disease, frogs possess both innate and adaptive immune systems, as
well as products metabolized by symbiotic skin bacteria (Harris et al., 2006, Harris et al.,
2009a, Brucker et al., 2008). The innate immune system is non-specific and acts quickly
upon infection by a pathogen. This system includes phagocytic cells, lysozymes, and
antimicrobial peptides (AMPs). The adaptive immune system includes antigen-specific T
and B lymphocytes that are created by previous exposure to their specified pathogen.
The adaptive immune system does play some role in defense against chytridiomycosis
as reduced lymphocyte numbers results in increased intensity of infection (Ramsey et
al., 2010). However, Bd has been shown to inhibit lymphocyte production and induce
apoptosis, which interferes with the development of an effective cell-mediated defense
(Fites et al., 2013a, Fites et al., 2013b). Since Bd infects the keratinized epidermal cells
of the skin, a frog’s cutaneous defenses are the first line of defense against
chytridiomycosis (Rollins-Smith et al., 2002b). Therefore, these defenses, which include
AMPs and cutaneous bacteria, may be very important in providing protection against
chytridiomycosis.

ANTIMICROBIAL PEPTIDES:
AMPs are synthesized in granular glands located on the frog’s skin where they
are stored as preproproteins (Bovbjerg, 1963, Mills and Prum, 1984, Rollins-Smith et al.,
3

2005). Activation of the sympathetic nervous system stimulates certain nerve receptors
in the muscle tissue surrounding these glands (Benson and Hadley, 1969, Dockray and
Hopkins, 1975, Sjöberg and Flock, 1976, Holmes and Balls, 1978), and the
preproprotein is cleaved to release an activated AMP (Resnick et al., 1991, Amiche et
al., 1999, Bowie et al., 1999). The activated peptide is secreted from the granular gland
and combined with mucous secreted from the frog’s cutaneous mucous glands, coating
the skin (Schumacher et al., 1994, Rollins-Smith et al., 2011, Gammill et al., 2012). Most
AMPs are cationic and characterized by hydrophobic regions (Nicolas and Mor, 1995,
Simmaco et al., 1998, Zasloff, 2002). They are therefore able to bind to negativelycharged regions on their target’s lipid membranes (Nicolas and Mor, 1995) and lyse their
target cells by either embedding into the membrane’s matrix or by creating disruptive
pores that leak intracellular material (Amiche et al., 1999, Conlon et al., 2004b,
Pasupuleti et al., 2012).
Early research on frog AMPs focused on refining the methodology of collecting
and isolating them and identifying individual peptides (Dockray and Hopkins, 1975, Tyler
et al., 1992, Bowie et al., 1999). These isolates were then assayed against pathogens,
revealing that many peptides were effective against bacteria, fungi, protozoa, and
viruses (Nicolas and Mor, 1995, Simmaco et al., 1998, Conlon et al., 2004a, Apponyi et
al., 2004, Zasloff, 2002, Rinaldi, 2002). Research then shifted to a conservation
approach in response to amphibian declines. In vitro assays were developed to test frog
peptides for activity against pathogens like Bd (Rollins-Smith et al., 2002a, Rollins-Smith
et al., 2002b, Rollins-Smith et al., 2002c). Most of the peptides used in this early testing
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demonstrated anti-Bd activity, including those isolated from a declining frog susceptible
to Bd, Rana tarahuamara (Rollins-Smith et al., 2002c).
Drastic frog population declines in Australia led to extensive research on the
AMPs of Australian frogs. The peptide compositions of many of these frog species are
well documented (Bowie et al., 1999), and when assayed against Bd most of these
peptides inhibited growth regardless of source host susceptibility, although AMP
effectiveness did decrease with host susceptibility (Woodhams et al., 2007a). The AMPs
of the declining North American frog Rana muscosa have also been assayed for activity
against Bd, revealing that these frogs have a rich repertoire of anti-Bd AMPs despite
being susceptible (Woodhams et al., 2007b). Therefore, the presence of anti-Bd AMPs
does not always correlate with resistance to chytridiomycosis. This relationship has also
been demonstrated in other frogs from different families distributed worldwide, including:
Alytes obstetricans in Europe (Bosch and Rincón, 2008), Silurana tropicalis in Africa
(Parker et al., 2002), and Hylomantis lemur in South America (Conlon et al., 2007b).

CUTANEOUS BACTERIA:
The diverse community of bacteria that naturally occurs on frogs’ skins are
another important component to their immune systems. These bacteria are probably
established on the skin when frogs are young (Fierer et al., 2012). Species that exhibit
parental care may transmit bacteria vertically (Walke et al., 2011). Symbionts are also
probably transmitted horizontally during mating and hibernating aggregations or acquired
from the environment (Muletz et al., 2012). It is suggested that within an amphibian
community, cutaneous microbe composition vary more among species than across
5

space (McKenzie et al., 2012), indicating some sort of genetic regulation of symbiont
community structure. This microbial regulation may be controlled by the frog’s immune
system, such as AMPs (Fierer et al., 2012); however, the establishment and
composition of skin bacteria most likely depends on complex interactions among
microbes and with the host’s mucosome (Scheuring et al., 2012). There may also be
correlations between a frog’s diet and cutaneous microbe species richness, abundance,
and community structure. For example, groups of captive Agalychnis callidryas fed diets
varying in carotenoid composition/abundance differed in the skin microbes that they
harbored (Antwis et al., 2014).
While serving a variety of functions, some of these bacteria contribute to their
host’s immunity. They may destroy pathogens by excreting metabolites, inhibit pathogen
colonization by competition, or enhance other components of the host’s innate immune
system (Harris et al., 2006, Brucker et al., 2008, Flechas et al., 2012). As with AMPs,
cutaneous bacteria are currently being sampled and assayed for their effectiveness
against Bd (Harris et al., 2006, Flechas et al., 2012). Cutaneous bacteria have been
sampled from the skins of many frog species, cultured, and assayed in vitro for their
abilities to inhibit the growth of Bd. These assays typically involve growing a fungal
“lawn" of Bd across a petri dish and streaking the query bacteria on one side and a
negative control bacteria on the other side (Flechas et al., 2012, Brucker et al., 2008,
Harris et al., 2009a). Anti-fungal activity is measured by clear zones of inhibition around
the query bacteria. However, the design of these assays allow for only semi-quantitative
measurements of anti-Bd activity and it is difficult to control for the amount of Bd
zoospores tested (Bell et al., 2013). To mitigate these limitations a new co-culture assay
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has been developed with a design similar to the AMP-Bd inhibition assay developed by
Rollins-Smith (2002a) (Bell et al., 2013).
In the United States, the bacterium Janthinobacterium lividum occurs naturally on
many native amphibian species and produces the anti-fungal metabolite violacein
(Brucker et al., 2008). It has been demonstrated that this metabolite is capable of
inhibiting the growth of Bd in vitro (Brucker et al., 2008, Harris et al., 2009a). The
capabilities of J. lividum to protect amphibians from Bd has been studied extensively.
This bacterium naturally occurs on the salamander Plethodon cinereus, and when these
salamanders were experimentally augmented with J. lividum they had increased levels
of violacein and were more likely to survive experimental infection with Bd (Becker et al.,
2009). Additionally, experimentally removing J. lividum form the skins of P. cinereus
decreased an individual’s likelihood to survive experimental infection with Bd (Becker
and Harris, 2010).
Frogs in the mountain yellow legged frog complex also naturally harbor J. lividum.
Some of these frogs have been experiencing dramatic population declines due to
chytridiomycosis (Briggs et al., 2005, Rachowicz et al., 2006). However, it is suggested
that among and within mountain yellow legged frog species, populations with larger
quantities of anti-Bd bacteria do not experience declines (Woodhams et al., 2007a, Lam
et al., 2010). For example, more individuals from non-declining populations of Rana
sierrae may harbor more anti-Bd bacteria than individuals in declining populations of
Rana muscosa (Woodhams et al., 2007a). Additionally, a separate population of R.
muscosa that was found to be composed of a high number of individuals with anti-Bd
bacteria was not in decline (Lam et al., 2010). J. lividum was common among the anti-
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Bd bacteria found in these studies. This bacterium has been demonstrated to protect
susceptible R. muscosa from Bd infections in vivo because individuals exposed to J.
lividum prior to infection with Bd survived whereas those that were not inoculated with J.
lividum did not (Harris et al., 2009a). An emergency inoculation with J. lividum of a
declining population of R. muscosa in the wild was executed, and this population
continues to persist despite the presence of Bd (Vredenburg et al., 2011).

AMPS, CUTANEOUS BACTERIA, AND CONSERVATION:
The results accrued from research involving frog AMPs and cutaneous bacteria
and their abilities to inhibit the growth of Bd have inspired potential conservation
strategies. The most feasible of these strategies may be the application of anti-Bd
bacteria as probiotics by bioaugmentation therapy (Bletz et al., 2013). This strategy
involves amplifying the presence of naturally occurring beneficial symbionts to better
protect the host. Bioaugmentation with the anti-Bd bacterium J. lividum has already been
successful in vivo with both the salamander P. cinereus (in captivity) and the frog R.
muscosa (Harris et al., 2009a, Muletz et al., 2012, Vredenburg et al., 2011).
Perhaps bioaugmentation therapy could also be used to save wild populations of
susceptible frogs, but the transition from laboratory experiments to wild populations will
come with challenges. There has been little research on applying this strategy in natural
systems (Bletz et al., 2013), and abiotic factors will certainly influence the success of a
probiotic when applied in situ. For example, mineral composition in the soil may
influence the efficacy of bioaugmentation for plant crops in situ (Haas and Defago,
2005). For frogs, it is unrealistic that every individual in a threatened population could be
8

collected and treated with a probiotic. Fortunately, vertical and horizontal transfer would
help propagate the beneficial bacterium throughout a population (Walke et al., 2011,
Muletz et al., 2012). Also, the results from the extensive work done with the mountain
yellow legged frogs suggest that herd immunity, which occurs when a pathogen’s effects
are inhibited by a high proportion of immune hosts, may prevent Bd outbreaks
(Woodhams et al., 2007a, Lam et al., 2010). There is evidence that bioaugmentation
can occur via environmental vectors such as soil, which gives hope that this strategy
could be possible to implement without the need to catch frogs (Muletz et al., 2012).
One important limitation to bioaugmentation is that the bacterium used must
naturally occur on the host, and, depending on how it will be applied, in the environment.
Failed attempts have occurred when trying to use bacteria from other hosts. For
example, J. lividum could not be inoculated on the harlequin toad Atelopus zeteki
(Becker et al., 2011) from Panama, where J. lividum has not been reported. Similarly,
skin microbes (in the form of whole skin washings) could not be inoculated from the
glass frog Espadarana prosoblepon onto the rocket frog Colostethus panamansis (Küng
et al., 2014). Also, some anti-Bd bacteria fail to establish on frogs’ skins despite being
generously applied (Woodhams et al., 2012b, Küng et al., 2014). It has been proposed
that potential probiotics pass rigorous criteria testing before being considered for
bioaugmentation (Bletz et al., 2013).
The applications of anti-Bd AMPs towards conservation are less tangible given
the current research. In fact, there have been almost no attempts to apply what is known
about AMPs and their abilities to inhibit Bd towards protecting live frogs. In an unsuccessful attempt, anti-Bd AMPs from the resistant frog Pelophylax esculentens were
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applied to the susceptible toads Bufo bufo, but failed to protect toads from Bd infection
(Woodhams et al., 2012b).
Anti-Bd AMPs may not be successful when applied as a therapeutic agent, but, if
AMP expression is heritable, their presence within a population could be amplified via
selective breeding. There are captive reassurance colonies of Panamanian frog species
whose natural populations have declined because of Bd. These frogs would be ideal
candidates for a selective breeding strategy because the goal of the breeding program is
to release animals that will repopulate wild areas where Bd is present.
It has also been suggested that AMPs could be used as predictors of a species’
susceptibility to Bd. The lack of anti-Bd AMPs was shown to correlate with declining
populations in Bd afflicted Panamanian frog communities, suggesting that AMP profiles
could be used as an indicator of susceptibility (Woodhams et al., 2006c). However,
there are many susceptible species that have been found to produce AMPs in quantities
sufficient enough to protect them from Bd infection (Parker et al., 2002, Rollins-Smith et
al., 2002c, Woodhams et al., 2007a, Conlon et al., 2007a, Bosch and Rincón, 2008,
Conlon et al., 2007b). These findings suggest that this defense alone is not capable of
providing protection.

FUTURE RESEARCH:
The stronger correlation between chytridiomycosis resistance and anti-Bd skin
microbes compared to AMPs provides evidence that bacteria may play a more important
role in protecting frogs (Conlon et al., 2007b). It is even hypothesized that the reduction
of AMP expression in some species is selected for to accommodate beneficial bacteria
10

(Conlon, 2011). It is also possible that the growth of skin microbes is regulated by AMPs
(Küng et al., 2014) or that skin microbes enhance or mute the effects of AMPs; either
way both defenses are likely engaged in a complex relationship. A combination of AMPs
and a single bacterial metabolite (both from R. muscosa and both previously known to
inhibit the growth of Bd individually) was more efficient at inhibiting the growth of Bd in
vitro than either defense was alone (Myers et al., 2012). However, these laboratory
assays do not represent the natural balance of AMPs and skin bacteria because only a
bacterial metabolite was used.
Regardless, the relationship between AMPs and skin bacteria should not be
overlooked and future research should focus on untangling this complex relationship.
Rarely are the capabilities of both defenses analyzed within a particular frog species or
between species that differ in susceptibility to chytridiomycosis. In one example where
both were assayed, the resistant R. sierrae harbored more anti-Bd bacteria than the
susceptible R. muscosa, but the abilities of their AMPs to inhibit the growth of Bd did not
differ (Woodhams et al., 2007a). There are methods to independently remove each of
these defenses from a frog, so future research should focus on manipulating each
defense’s presence while conducting susceptibility trials.
A large database consisting of the anti-Bd capabilities of susceptible and
resistant species’ AMPs and bacteria could support a meta-analysis that would help
elucidate which defense is most important. This information would be even more useful
if resolved to the population level, as different populations of the same species can vary
in their compositions of AMPs and bacteria (Lam et al., 2010, Woodhams et al., 2010b,
Holden et al., 2015).

11

When searching for mitigation strategies it is easy to focus only on the effect that
the defense has on a pathogen and ignore the effect that a pathogen may have on a
defense. Bd has been shown to impair the adaptive immune system in frogs (Fites et al.,
2013b), and therefore could also impair their innate immune system. Recent evidence,
from the laboratory and the field, suggests that Bd infection load can influence
cutaneous bacteria compositions on R. sierrae by promoting the growth of certain
bacterial taxa and inhibiting the growth of others (Jani and Briggs, 2014). Of the bacteria
whose abundances were negatively correlated with Bd load, several belonged to genera
that are known for their anti-Bd capabilities. However, a previous study examining the
cutaneous bacteria of R. sierrae demonstrated that no strains belonging to these genera
were capable of inhibiting Bd (Roth et al., 2013).
Still, this research provides evidence that at least some bacterial species
belonging to these beneficial genera are sensitive to Bd, and that the impact of Bd
infection on a frog’s skin bacteria should not be overlooked. Similar laboratory and field
studies should be conducted with other frog species whose compositions of anti-Bd and
non-anti-Bd bacteria are known to determine how Bd infection load influences these
compositions. Cutaneous bacteria can also be sampled and assayed against Bd before
and after experimental infection of the host to determine if anti-Bd or non-anti-Bd
bacteria change in response to infection. It would also be important to determine the
mechanism that drives any observed changes in the bacterial community due to
pathogen infection. These mechanisms could be direct (i.e. microbial composition) or
indirect (i.e. a result of host behavior in response to infection). It is equally as important
to examine the effects that Bd load can have on AMPs, although the natural brevity of
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AMPs existence on the skin (approximately 2 hours [(Pask et al., 2012)]) may
overshadow any observable effects.
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CHAPTER 2
THE IDENTIFICATION OF ANTI-BATRACHOCHYTRIUM DENDROBATIDIS SKIN
BACTERIA IN PERUVIAN MARSUPIAL FROGS
INTRODUCTION
The skin is arguably an amphibian’s most important organ. This integument is
responsible for most of the animal’s respiration and osmoregulation. With form matching
function, amphibian skin has a permeable design that facilitates diffusion and osmosis.
Unfortunately this sensitive membrane also allows easy access for infectious pathogens
so cutaneous defenses are especially important for amphibians. One particular
pathogen, the chytrid fungus Batrachochytrium dendrobatidis (Bd) (Longcore et al.,
1999), invades amphibian skin with motile zoospores, which encyst and proliferate in
keratinized dermal tissue (Berger et al., 2005a, Kilpatrick et al., 2010). Eventually, the
functionality of the integument is interrupted with the onset of the disease
chytridiomycosis (Berger et al., 2005b). This pathogen is of particular conservation
concern because of its recent global spread and lethal effects (Stuart et al., 2004).
Understanding the role of skin defenses in infection may lead to the development of
novel mitigation strategies against Bd.
Amphibian skin is coated with a mucous consisting of a micro-environment, or
mucosome, patrolled by components of both their adaptive and innate immune systems
(Rollins-Smith et al., 2005). Protection is also provided by symbiotic bacteria (Harris et
al., 2006). The bacteria that inhabit amphibian skin are likely established at a young age
through environmental transmission from soil and water, although any sharing of refugia
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is also likely to be an inter-individual source of inoculation, and for species with paternal
care vertical transmission is probable (Walke et al. 2011, Fierer et al. 2012, Muletz et al.
2012). Amphibian skin often has a diverse microbial community (Jani and Briggs, 2014).
Compositions are typically species-specific but can vary among populations within a
species that is distributed over a wide geographic range (McKenzie et al., 2012, Lam et
al., 2010). Some of these bacteria protect their hosts by secreting metabolites to destroy
invading pathogens (Brucker et al., 2008) and may also outcompete pathogens for
space on the skin (Belden and Harris, 2007).
Certain bacteria isolated from the skin of amphibians that are resistant to
chytridiomycosis (henceforth, anti-Bd bacteria) have demonstrated the ability to inhibit
the growth of Bd in in vitro co-culture assays (Flechas et al., 2012, Harris et al., 2006,
Park et al., 2014). Metabolites isolated from cutaneous bacteria can also inhibit the
growth of Bd alone (Loudon et al., 2014, Brucker et al., 2008), and it is suggested that
zoospores actually avoid these metabolites through chemotaxis (Lam et al., 2011).
Salamanders known to resist Bd infection experienced symptoms indicative of
chytridiomycosis in experimental removals of anti-Bd bacteria (Becker and Harris, 2010).
Additionally, the experimental addition of anti-Bd bacteria to susceptible amphibian
species has ameliorated the effects of chytridiomycosis (Becker et al., 2009, Harris et
al., 2009a, Harris et al., 2009b), suggesting that bioaugmentation therapy with probiotics
may be a prophylactic strategy.
The inhabitants of an amphibian’s skin appear to be highly regulated (Belden and
Harris, 2007). A protocol to select anti-Bd bacteria for bioaugmentation suggests using
bacteria already known to naturally inhabit the particular host species’ skin (Bletz et al.,
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2013), as not doing so has resulted in unsuccessful inoculation attempts (Becker et al.,
2011) and could introduce bacteria that disrupt the natural bacterial communities.
Therefore, the natural microbiome must be examined for any susceptible species
intended to be treated by probiotics, requiring sampling across a diverse taxa. There is
currently a database of bacterial strains known to inhibit Bd which includes their
probable identities and their hosts (Woodhams et al., 2015). As the size of this database
increases, the number of frog species it could help protect may also increase.
Although symbiotic bacteria are just one of many components of an amphibian’s
defensive mechanisms against pathogens, they are of particular importance for
providing protection against Bd. Zoospores, the infectious life stage of Bd, must first
penetrate an amphibian’s skin to infect its host (Berger et al., 2005a), emphasizing the
importance of the many innate defense mechanisms that patrol this integument. It is
unclear if the adaptive immune system plays a vital role in protecting frogs from Bd
(Berger et al., 1998a, Pessier et al., 1999, Berger et al., 2005b, Woodhams et al.,
2007a). Bd may impair the development of adaptive cell-mediated defenses because
experimental exposure of frogs to heat-killed Bd zoospores failed to induce a
subsequent protective immune response (Stice and Briggs, 2010). The presence of
lymphocytes does not increase in infected frogs (Woodhams et al., 2007a). It has even
been demonstrated that Bd can impair lymphocytes via apoptosis in vitro (Fites et al.,
2012) and may also impair a systemic immune response in vivo (Young et al., 2014). On
the contrary, recent research does suggest that previously exposed frogs do acquire an
immune response to Bd (McMahon et al., 2014), but only after several exposure and
treatment regimens. Antimicrobial peptides (AMPs) have demonstrated the ability to
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inhibit the growth of Bd in vitro (Conlon et al., 2013, Ramsey et al., 2010, Rollins-Smith
et al., 2002c). However, even frog species susceptible to chytridiomycosis produce antiBd AMPs (Rollins-Smith et al., 2002c, Woodhams et al., 2007b, Bosch and Rincón,
2008, Parker et al., 2002, Conlon et al., 2007b),.
Amphibians are one of the most endangered vertebrate groups (Stuart et al.,
2004), so developing mitigation strategies is critical. It is also unlikely that Bd will be
eradicated from the environment, so mitigation strategies will rely on treatment or
prophylactic methods directed at hosts. Although chytridiomycosis can currently be
treated by the application of various anti-fungal drugs (Jones et al., 2012, Hadfield and
Whitaker, 2005, Garner et al., 2009, Bowerman et al., 2010, Martel et al., 2011) or by
heat therapy (Woodhams et al., 2003, Geiger et al., 2011, Chatfield and RichardsZawacki, 2011), these treatments aren’t always effective (Woodhams et al., 2012b) and
would be difficult to apply in situ. Strategies that can protect vulnerable frogs may allow
for populations to persist in their natural environment, and may improve understanding
of how defenses like bacteria contribute to chytridiomycosis resistance and will guide
future mitigation strategies.
We tested if cutaneous bacteria are important in protecting wild marsupial frogs in
a community decimated by Bd in Andean Peru (Catenazzi et al., 2011). Female
marsupial frogs possess a dorsal brood pouch where fertilized eggs are stored until
hatching. Then, depending on the species, either tadpoles are deposited into water, or
embryos complete their development inside the pouch and emerge as froglets
(Weinland 1854(del Pino and Escobar, 1981). Recently, cutaneous bacteria were
identified from Ecuadorian marsupial frogs that have tadpoles (Bresciano et al., 2015).
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The species of focus in our study, Gastrotheca nebulanastes and G. excubitor, develop
directly from egg to froglet (Duellman and Maness, 1980). Prevalence of Bd infection
was similar in these species in 2008 and 2009 (Catenazzi et al., 2011).
A previous study exposed both G. nebulanastes and G. excubitor to high
numbers of zoospores in Bd susceptibility trials. The results indicated that G.
nebulanastes is susceptible to chytridiomycosis (16.6% survival) while G. excubitor is
resistant (100% survival) (Catenazzi, Vredenburg et al. unpublished) (Figure 1). To test
if cutaneous bacteria contributed to the observed difference in susceptibility, bacteria
were collected from individuals of both species. Isolates of these bacteria were then
tested for their abilities to inhibit the growth of Bd in co-culture assays. Growth inhibition
was quantified by measuring the change in the density of Bd colonies. The identities of
the isolates were also determined via BLAST searches of the sequences of their 16S
ribosomal RNA genes, and bacterial compositions were compared between the two host
species, as well as with other frog species (Woodhams et al., 2015, Bresciano et al.,
2015).

METHODS
Study species and site
Frogs were collected along the Paucartambo-Shintuya road in the eastern slopes
of the Cordillera de Paucartambo, Cusco, Peru from June to August of 2012.
Gastrotheca excubitor were collected in high elevation grasslands above 3,000 m and
G. nebulanastes were collected in the montane scrub forests between 2,000 and 3,000
m (Duellman et al., 2011). We captured juveniles and adults of both sexes. All frogs
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were housed in individual plastic bags and taken to nearby Wayqecha Biological Station
for bacterial and Bd sampling.

Bacterial Sampling
Samples of cutaneous bacteria were collected from 12 G. excubitor and 8 G.
nebulanastes. Frogs were handled using sterile nitrile gloves and were rinsed twice with
dechlorinated water to remove transient bacteria (Lauer et al. 2007). Frogs were then
swabbed on their left, right, and ventral surfaces, hindlimbs, and interdigital membranes
using a sterile cotton swab (Flechas et al. 2012). Each swab was streaked onto a Petri
dish of nutritive agar and incubated at room temperature for up to two weeks. After this
time Petri dishes were examined for bacterial growth and each bacterial morphotype
(identified on the basis of color, form, elevation, and margin) was streaked onto a new
plate with nutritive agar. This process was repeated until only similar morphotypes were
consistently observed, at which time, a small portion of each isolate was collected onto a
sterile cotton swab which was stored in a sterile vial. These were then transported to the
laboratory for Bd growth inhibition assays, sequencing, and cryopreservation (nutritive
broth with 30 % glycerol at – 80°C).

Batrachochytrium dendrobatidis growth inhibition assays
Each bacterial isolate was tested for its ability to inhibit the growth of Bd in a coculture assay (Harris et al. 2006) at Universidad de los Andes in Bogotá, Columbia. We
isolated the Bd strain used in these assays from the mouthparts of a Hypsiboas gladiator
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(Anura, Hylidae) tadpole captured along the Paucartambo-Shintuya road in June of
2012. Bd was maintained in culture on TGh medium (10 g tryptone, 10 g agar, 4 g
gelatin hydrolysate, 1 L distilled water) at 23˚C (Flechas et al. 2012). After maximum
zoospore production was observed, Bd was harvested and combined in a sterile tube
with 16 mL of sterile water. One mL of this zoospore rich solution was spread on to a
Petri dish containing TGh medium and allowed to dry. An unknown isolate of bacteria
from frog skin was streaked in a line across one side of the Petri dish, and as a negative
control, Escherichia coli (strain DH5α), which does not inhibit the growth of Bd, was
streaked across the other side of the Petri dish. Assays were set up in triplicate. Petri
dishes were checked daily for contamination, and if a dish was contaminated it was
removed and discarded. This was the reason for the removal of two replicates of one
isolate and one replicate of another. Each Petri dish was grown at 23˚C for three days.
On the third day each Petri dish was checked for Bd inhibition by the presence of a clear
zone of inhibited Bd growth around the isolate.
Analysis of inhibition assays
The strength of a particular isolate’s ability to inhibit Bd was determined by
quantifying the distance from the isolate to where 50% Bd growth occurred. Thus,
isolates with stronger inhibitory abilities depressed Bd growth over longer distances. For
one replicate it was unclear where 50% growth occurred; the sigmoidal shape of the
graphed points surpassed this value twice (Figure 3). This was likely due to sparse and
uneven Bd growth on the Petri dish; this replicate was removed from analysis.
Bd growth was initially recorded by measuring the grey values of standardized
photographs of the Petri dishes using ImageJ software (Abramoff et al., Flechas et al.,
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2012). Grey values (hereafter referred to as “growth”) are measurements of the intensity
of light in a pixel of a black and white image. Growth was averaged among pixel wide
columns across the area between the query bacterium and negative control, thereby
quantifying growth over minute distance increments from the query. Distances between
the query and the negative control varied slightly between Petri dishes, so they were
expressed as percentages of the total length (i.e. relative distance) to facilitate
comparative analysis. Growth was also expressed as percentage of the maximum
growth recorded to control for any variation between Petri dishes. For each replicate,
values were plotted on a graph using Microsoft Excel (Microsoft Corporation, Redmond,
WA, USA). The distance at where 50% growth occurred was determined using the
function of a line fit to the graphed values. We report average relative distance and
standard error calculated across the three replicates of each isolate.
Identification of bacteria
Bacterial isolates were identified by sequencing the 16S ribosomal RNA (rRNA)
gene. Swab samples of each isolate were stored frozen before processing. DNA was
extracted from each swab using 80 µL Prepman Ultra Sample Preparation Reagent (Life
Technologies Corporation, 2010). Tubes were then thoroughly vortexed, incubated at
100°C for 10 min., cooled for 2 min., and then centrifuged at 1300 rpm for 3 min.
Afterwards, 40 µL of the supernatant was removed and placed into a new sterile tube.
This DNA-rich liquid was diluted with sterile water at a ratio of 1:100. A PCR reaction
was performed using the diluted DNA as a template and the universal 16S bacterial
primers 27F (5’-AGAGTTTGATCCTGGCTCAG-3’) and 1492R (5’GGTTACCTTGTTACGACTT-3’) (Lane, 1991). Each PCR reaction contained 1 µL of
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each primer, 2 µL of the DNA template, 8.5 µL of sterile water, and 12.5 µL of GoTaq
Green Master Mix (Promega Corporation, Madison, WI, USA). Thermocycling conditions
were as follows: initial denaturation at 95°C for 2 min., 30 cycles at 95°C for 30 s, 60°C
for 30 s, and 72°C for 90 s, and a final extension at 72°C for 10 min. Amplification was
verified by electrophoresing 5 µL of the PCR sample on a 2% agarose gel. PCR
products were cleaned using EXO-Sap It (Affymetrix, Inc, Santa Clara, CA, USA) and
sent to MCLAB in San Francisco, California for sequencing.
Sequences were annotated and assembled using GENIOUS software
(Biomatters Limited, Auckland, New Zealand). All sequences were first checked for
quality and only those with forward and reverse sequences consisting of at least 60%
high quality base pairs were utilized. Assembled sequences were referenced to known
microbial DNA sequences using the BLAST search of the NCBI database within
GENEIOUS using the default parameters. Sequences were also cross referenced with
the Greengenes database (http://greengenes.lbl.gov) using the default parameters to
verify identities. Identities of nearest relatives were approximated to either the genus or
species level (depending on the results of the BLAST searches) based upon the identity
grades of the BLAST results.
Sampling for Bd
All individuals collected during the field sampling were swabbed for the presence
of Bd. Sterile cotton swabs were streaked five times on each side of the animal,
between its front and rear limbs, five times on the ventral “drink patch,” five times on the
upper portion of each of the legs, and once on each interdigital membrane of the hind
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feet (Hyatt et al., 2007). The swabs were immediately placed into individual sterilized
vials and stored for processing.
Swab samples were analyzed using real-time quantitative PCR (qPCR). DNA was
extracted from swabs using PrepMan Ultra following the protocol outlined in Boyle et al.
(2004) and Hyatt et al. (2007), except extracts were analyzed once instead of three
times (Vredenburg et al., 2010). An Applied Biosystems Instrument 7300 PCR machine
was used to quantify the amount of DNA in each sample. We calculated ZE, the
genomic equivalent for Bd zoospores (henceforth “zoospores”) by comparing the qPCR
results to a set of standards from live cultures.

RESULTS

Identification of bacteria via morphology and RNA sequencing
A total of 24 bacterial morphotypes were isolated form the study species, 14 from
G. excubitor and 10 from G. nebulanastes (Table 1). The nearest relatives for three of
the anti-Bd strains (see below) isolated from G. excubitor were: Sphingobacterium
faecium (99.7% identity grade), Janthinobacterium lividum (99.9% identity grade), and
Rahnella aquatilis (99% identity grade) and were labeled as strains of these species.
The other two isolates from G. excubitor were identified as members of the genus
Pseudomonas, but because they lacked a clear nearest relative on the species level
were designated with the labels Pseudomonas sp. 1 and Pseudomonas sp. 2. The
nearest relatives for Pseudomonas sp. 1 are P. mandelii, P. poae, and P. trivialis (all
99.4% identity grades). The nearest relatives for Pseudomonas sp. 2 are P. fluorescens,
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P. poae, and P. trivialis (all 100% identity grades). These similar BLAST results indicate
that these two isolates are probably closely related. However, they are morphologically
distinct in culture.
The single anti-Bd bacterium isolated from G. nebulanastes also belongs to the
genus Pseudomonas. Due to ambiguity with identifying this isolate’s nearest relative on
the species level, it was labeled Pseudomonas sp. 3. The two nearest relatives of
Pseudomonas sp. 3 (100% identity grade) are also currently unidentified to the species
level, but they are closely related to P. baetica and P. koreensis (99.9% identity grade).
Among non-anti-Bd isolates (see below), one isolated from G. excubitor, had the
same sequences of Pseudomonas sp. 2, suggesting variability in this isolate’s Bd
inhibitory abilities. Six others from G. nebulanastes all had many nearest relatives within
the genus Psuedomonas, including some that were shared with the Pseudomonas antiBd isolates such as P. poae (99.9% identity grade), P. fluorescens (99.9% identity
grade), and P. baetica (100%). The nearest relatives for several non-anti-Bd isolates
were identified to the species level, including Microbacterium oxydans (99.9 %) and
Bacillus simplex (100% identity grade) from G. nebulanastes, and Aeromonas hydrophila
(100%) and Acinetobacter radioresistens (99.9% identity grade) from G. excubitor.
Batrachochytrium dendrobatidis growth inhibition assays
From the inhibition assays, six out of the total 24 bacterial isolates tested
produced zones of Bd inhibition. Of these, five came from G. excubitor and one from G.
nebulanastes, so about a third of G. excubitor (five out of 14) isolates but a tenth of G.
nebulanastes isolates (one out of 10) were labeled as anti-Bd (figure).
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Analysis of the inhibition assays indicated that the bacterium labeled as
Pseudomonas sp. 2, isolated from G. excubitor, had the strongest ability to inhibit the
growth of Bd, with 50% Bd growth measured occurring at 66% of the total distance
(Figure 4, Table 1). The J. lividum strain had the weakest inhibitory ability of all of the
bacteria isolated from G. excubitor. For this isolate, 50% of Bd growth occurred at 40%
of the total distance (Figure 4). The one isolate from G. nebulanastes that was inhibitory
against Bd, Pseudomonas sp. 3, was the weakest of all the isolates from both species.
For this isolate, 50% of Bd growth occurred at 38% of the total distance (Figure 4).
Prevalence and infection load for Bd
Only four G. nebulanastes (prevalence= 25%, CI=7.6%-46.8%) but 13 G.
excubitor (prevalence= 46.4%, CI=28.9%-64.3%) tested positive for Bd. All Bd positive
frogs had low infection loads (< 350 zoospore), except for one G. excubitor, with
26,208.8 zoospore.

DISCUSSION
The frog species resistant to chytridiomycosis, G. excubitor, harbors more
cultivable anti-Bd skin bacteria than a susceptible congeneric, G. nebulanastes.
Gastrotheca excubitor also has proportionally more cultivable bacteria that inhibit the
growth of Bd than G. nebulanastes (36% versus 10%, respectively). These results
suggest that chytridiomycosis resistance may be correlated with the number and
proportion of a frog species’ anti-Bd skin bacteria. This relationship has also been
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suggested by other studies that found similar results (Park et al., 2014, Woodhams et
al., 2007b, Lam et al., 2010, Lam et al., 2008, Flechas et al., 2012).
All of the six anti-Bd bacterial morphotypes had relatively similar strengths of
inhibition with distances to 50% Bd growth ranging from 38%-66% of the total distance
(Figure 4). The isolate with the strongest ability to inhibit Bd belongs to the genus
Pseudomonas (Figure 4). Two other isolates were identified as members of this genus,
the fourth strongest and the weakest (Figure 4, Table 1). Pseudomonas bacteria are
common inhabitants of frog skin and are frequently characterized by having strong antiBd properties (Flechas et al., 2012, Walke et al., 2011, Brucker et al., 2008, Lam et al.,
2010). The nearest relatives of two isolates, S. faecium and J. lividum, are known for
their anti-Bd abilities; for example S. faecium has been isolated from Alytes obstetricans
in Switzerland, a toad species whose susceptibly to Bd varies by population (Tobler and
Schmidt, 2010).
The presence of J. lividum on the skin of G. excubitor is of particular interest.
Anti-Bd strains of this bacterium have been isolated from multiple species of amphibians
from Europe and the United States (Woodhams et al., 2015). This bacterium has also
been applied successfully as a probiotic in laboratory experiments (Harris et al., 2009b,
Harris et al., 2009a) and in one emergency application to a declining population of Rana
muscosa in the wild (Vredenburg et al., 2011), although the latter experiment did not
have a control group. Despite J. lividum being well-known for the strong anti-Bd
properties of its metabolites violacein and indole-3-carboxaldehyde (Brucker et al.,
2008), the closely related strain that we isolated was ranked as the second weakest out
of six isolates (Figure 4). Our strain also lacks the distinctive purple coloration
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characteristic of J. lividum in culture, attributed to the production of violacein. It is
possible that our strain does not produce violacein but still produces indole-3carboxaldehyde, making it less able to inhibit Bd than other J. lividum strains.
Although not previously known for its ability to inhibit the growth of Bd, we found
that Rahnella aquatilis, isolated from G. excubitor, was a relatively strong inhibitor of Bd
(Figure 4). This bacterium has been documented as an antifungal symbiont of the
Chinese beetle Dendroroctonus valens (Winder et al., 2010). The two isolates from G.
excubitor in the genus Pseudomonas were both closely related to Pseudomonas poae
(99.4% identity grade for Pseudomonas sp. 1 and 100% identity grade Pseudomonas
sp. 2), documented as an antifungal symbiont of the sugar beet (Müller et al., 2013).
Although both the isolates Pseudomonas sp. 1 and Pseudomonas sp. 2 had similar 16S
rRNA sequences, their morphologies were distinct and they differed in their abilities to
inhibit Bd (with 50% Bd growth occurring at 43.33% and 65.94% of the total distances,
respectively). We found that a non-anti-Bd isolate was also identified as Pseudomonas
sp. 2 because of their identical 16S rRNA sequences. Additionally, several non-anti-Bd
Pseudomonas isolates shared similar nearest relative BLAST results to these anti-Bd
Pseudomonas strains. These findings suggest that functional variance can occur
between closely related, or even same-species, strains.
The one anti-Bd strain from G. nebulanastes, labeled as Pseudomonas sp. 3,
shares a 100% identity grade with a bacterium isolated from peat moss in the United
Kingdom (Hill et al., 2014) and another, capable of producing aromatic compounds,
isolated from soil underneath logs in the Netherlands (Bandounas et al., 2011). The
latter is closely related to another bacterium with documented antifungal properties; it is
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pathogenic to the mushroom Agaricus bisporus (Godfrey et al., 2001). Although labeled
as anti-Bd on the basis of its inhibition zone in one replicate, the removal of the second
replicate (see methods) brings into question the integrity of its inhibitory abilities.
Therefore, we label Pseudomonas sp. 3 as potentially anti-Bd and suggest further
testing to verify its anti-Bd ability.
None of the bacteria identified were shared between the two Gastrotheca
species. These frogs differ in the niches that they inhabit, with G. excubitor dwelling
under rocks and among bunchgrasses on the ground of grasslands and G. nebulanastes
in the bushes and trees of the scrub forest. Our findings suggests that the environment
might be an important source of inoculation for skin bacteria. We also found that only J.
lividum and Aeromonas hydrophila, isolated from G. excubitor, were shared with the
Ecuadorian congeneric G. riobambae sampled by Bresciano et al. (2015). Interestingly,
this study considered A. hydrophila as anti-Bd, and we did not. However, unlike our
study, Bresciano et al. (2015) did not conduct growth inhibition assays to validate the
classification of their bacteria. This difference, along with our varying results for
Pseudomonas sp. 2, exemplifies the importance of considering the variance in the
antimicrobial abilities of closely related strains.
The results of our study support the notion that cutaneous bacteria may be
important in providing frogs with protection against Bd (Conlon et al., 2007b). Previously,
it had been suggested that frogs fail to develop an adaptive immune response (Stice
and Briggs, 2010) and that proliferation of lymphocytic cells is hindered by Bd (Fites et
al., 2012). In addition, the expression of AMPs does not consistently correlate with
resistance to Bd (Rollins-Smith et al., 2002c, Woodhams et al., 2007b, Bosch and
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Rincón, 2008, Parker et al., 2002, Conlon et al., 2007b), and the reduction of these
defenses has not been demonstrated to increase susceptibility (Woodhams et al.,
2012a) as does the reduction of anti-Bd skin bacteria (Becker and Harris, 2010). A
concurrent study conducted by our group found that natural mixtures of AMPs collected
from G. excubitor and G. nebulanastes did not differ in their abilities to inhibit the growth
of Bd in vitro, emphasizing the role of the anti-Bd bacteria found here in protecting G.
excubitor.
The use of anti-Bd bacteria in bioaugmentation therapy is promising, but the strict
requirements of potential probiotics (Bletz et al., 2013) will require wide scale sampling
of cutaneous microbes from many frog species. Here we have discovered at least four
novel anti-Bd strains that will contribute to the library of these potential candidates. We
did not, however, find any anti-Bd isolates shared between the Gastrotheca species,
which suggests that similarities in cutaneous bacterial compositions cannot be assumed
between congeneric species. Bletz et al. (2013) recommends as probiotic a bacterium
that naturally occurs on the susceptible frog. In our study, the only candidate for
bioaugmentation therapy for G. nebulanastes is Pseudomonas sp. 3, whose anti-Bd
capabilities are questionable. If its inhibitory abilities are eventually verified, however,
this bacterium should be considered as a candidate for bioaugmentation therapy with G.
nebulanastes. Since the females of this species keep eggs in their dorsal brood pouch
until the hatching of froglets (Duellman et al., 2011), vertical transmission of cutaneous
bacteria between a mother and offspring is likely. Therefore, a probiotic applied to a
portion of wild females of this species may proliferate throughout generations.
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CONCLUSIONS:
The process towards developing an effective mitigation strategy for
chytridiomycosis is an iterative approach that continues to unveil the complexity of the
host-pathogen system. It is likely that bacteria may provide an answer and the results of
our research are encouraging. The intricate ecology of the frog mucosome must first be
untangled to know for certain. Outside the scope of the frog’s immune system, inter- and
intraspecific interactions, environmental factors, and anthropogenic forces likely play
major roles in the patterns of either post-Bd population declines or persistence. Despite
this daunting complexity, however, each discovery is a step forward towards
understanding the host-pathogen relationship and brings hope for saving an imperiled
animal group.

30

Table 1: Species of cultured bacteria isolated from Gastrotheca excubitor and G.
nebulanastes

______________________________________________________________________
Bacterial Species

G. exc.

G. neb.

Anti-Bd

Rank of anti-Bd

Actinobacteria
Actinomycetales: Microbacteriaceae
Microbacterium oxydans

-

+

No

Microbacterium sp.

+

-

No

+

-

No

+

-

Yes

Bacillus simplex

-

+

No

Bacillus sp.

-

+

No

-

+

No

+

-

No

Bacteroidetes
Flavobacteriales: Flavobacteriaceae
Chryseobacterium sp.

Sphingobacteriales: Sphingobacteriaceae
Sphingobacterium faecium
Firmicutes
Bacillales: Bacillaceae

Bacillales: Paenibacillaceae
Paenibacillus sp.
Proteobacteria
Aeromonadales: Aeromonadaceae
Aeromonas hydrohphila
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3

Table [1]: Continued

Bacterial Species

G. exc.

G. neb.

Anti-Bd

Rank of anti-Bd

Burkholderiales: Oxalobacteraceae
Janthinobacterium lividum

+

-

Yes

5

Rahnella aquatilis

+

-

Yes

2

Serratia sp.

+

-

No

+

-

No

Pseudomonas sp. 1

+

-

Yes

4

Pseudomonas sp. 2

+

-

Yes

1

Pseudomonas sp. 3

-

+

Yes

6

Pseudomonas sp. 4

-

+

No

Pseudomonas sp. 5

-

+

No

Pseudomonas sp. 6

-

+

No

Pseudomonas sp. 7

-

+

No

Pseudomonas sp. 8

-

+

No

-

No

Enterobacteriales: Enterobacteriaceae

Pseuodomonadales: Moraxellaceae
Acinetobacter radioresistens
Pseudomonadales: Pseudomonadaceae

Sphingomonadales: Sphingomonadaceae
Sphingomonas sp.

+

______________________________________________________________________
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Figure 1: Kaplan-Meier Survival Curves for G. nebulanastes (top) and G. excubitor
(bottom). The infected group is represented in black and the control group in red.
Infected and control G. excubitor did not differ in survivorship.
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Figure 2: Examples of bacterial isolates exhibiting clear zones of Bd inhibition and
therefore designated as anti-Bd.
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Figure 3: The growth inhibition curve for a replicate of the Pseudomonas sp 3 isolate.
Because the line of this graph passes through 50% growth (0.32% total Bd growth
based on the equation of the line) twice, it was excluded from further analysis.
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Figure 4: Mean distances (with standard errors) to 50% growth for each isolate.
Sphingobacterium faecium and Pseudomonas sp. 3 do not have standard error bars
because they each had only 1 replicate.
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CHAPTER 3
SUSCEPTIBILITY TO CHYTRIDIOMYCOSIS DOES NOT CORRELATE WITH
ANTIMICROBIAL ABILITIES OF CUTANEOUS PEPTIDES IN TWO SPECIES OF
MARSUPIAL FROGS
INTRODUCTION
Antimicrobial peptides (AMPs) are an important component of the innate immune
system for many organisms including both vertebrates and invertebrates. AMPs are
functionally diverse but all share the ability to form an amphipathic shape characterized
by distinct hydrophobic and cationic amino acid groups. This structure allows AMPs to
efficiently target cellular membranes and induce lysis (Amiche et al., 1999, Conlon et al.,
2004b, Pasupuleti et al., 2012). An AMP’s positive charge facilitates binding to bacterial
or fungal outer membranes which are composed of many negatively charged
phospholipids (Nicolas and Mor, 1995, Zasloff, 2002). Because of its hydrophobicity, an
AMP can also penetrate its target’s cellular membrane, creating fatal pores (Yang et al.,
2000). It is suggested that cellular death is induced by depolarization of the membrane
(Westerhoff et al., 1989), reorganization of the lipid bilayer (Matsuzaki, 1999), or by the
peptide entering the cell and disrupting enzymatic activity (Kragol et al., 2001).
Evolutionarily, AMPs are an ancient defense mechanism and are therefore
probably important for basal vertebrates like amphibians. Invasion of pathogens through
porous skin is problematic for these animals, emphasizing the efficiency of cutaneous
defenses like AMPs. It is suggested that AMPs may even assist with the delivery of
neuroactive peptides in toxic amphibians by disrupting the cellular membranes of their
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predators (König et al., 2015, Conlon, 2011). Because they can be proficient killers,
especially in anurans, amphibian AMPs have been tested for biomedical applications,
demonstrating activity against Chlamydia trachomatis (Bergaoui et al., 2013), human
immunodeficiency virus (VanCompernolle et al., 2005), and tumor cells (Mechkarska et
al., 2014).
In frogs, activation of the sympathetic nervous system stimulates cutaneous
granular glands to release AMPs which are combined with a mucous to coat the skin
(Bovbjerg, 1963, Mills and Prum, 1984, Rollins-Smith et al., 2005). Since they are
present on the skin, AMPs could play a role in protecting frogs from cutaneous
pathogens like the fungus Batrachochytrium dendrobatidis (Bd) (Longcore et al., 1999).
This pathogen has caused numerous frog population collapses in many parts of the
world (Berger et al., 1998a, Daszak and Berger, 1999, Skerratt et al., 2007, Fisher et al.,
2009). Bd infects frogs via motile zoospores that encyst on their skin (Berger et al.,
2005a, Kilpatrick et al., 2010) and can cause the fatal disease chytridiomycosis (Berger
et al., 2005b).
Natural peptide mixtures collected from frogs have successfully demonstrated the
ability to inhibit the growth of Bd in laboratory assays (Rollins-Smith et al., 2002c,
Conlon et al., 2013, Woodhams et al., 2010a, Ramsey et al., 2010). The collection of
peptides is typically induced by injecting the frog with norepinephrine to stimulate its
sympathetic nervous system (Rollins-Smith et al., 2002c, Nutkins and Williams, 1989).
Bd growth inhibition is then assayed using different dilutions of natural peptide mixtures
to establish a minimum inhibitory concentration (MIC) where growth of a known number
of zoospores is completely inhibited (Woodhams et al., 2006b, Rollins-Smith et al.,
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2006). MIC values can be used to compare the relative effectiveness of AMPs among
individuals or species.
Here, we analyze peptide samples from two marsupial frogs, Gastrotheca
excubitor and G. nebulanastes. Whole peptide mixtures collected from these frogs were
tested for their abilities to inhibit the growth of Bd in vitro and the peptide profile of each
sample was generated by mass spectrometry. The results contribute to understanding
the role that AMPs play in protecting frogs from chytridiomycosis because G. excubitor is
resistant and G. nebulanastes is susceptible (Catenazzi, Vredenburg et al. unpublished).
These species live in the Andes Mountains of south eastern Peru, where surveys
indicate that anuran species diversity was reduced by approximately 36% following the
arrival of Bd at the turn of the millennium (Catenazzi et al., 2011).

METHODS

Study species
Marsupial frogs (family Hemiphractidae) occur from Central America to southern
South America. These frogs are unique in that the females possess a dorsal brood
pouch where eggs develop until hatching as either a tadpole or a froglet (directdeveloping) depending on the species (Weinland 1854, del Pino and Escobar, 1981).
Both G. nebulanastes and G. excubitor are medium-sized, direct-developing frogs
endemic to the Andean region of southeastern Peru. These two species are
morphologically similar and were thought to be the same species until 2011 (Duellman et
al., 2011). The susceptible G. nebulanastes inhabits montane scrub and cloud forests
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from 2,000-3,300 m. They are primarily found on shrubs and the rocks of cliffs caused
by landslides or along roads (Duellman et al., 2011). The resistant G. excubitor is
marginally sympatric to G. nebulanastes but lives above 3,100 m on vegetation in highAndean grasslands.
Study site
Field work was conducted in the Kosñipata Valley of southeastern Peru. Surveys
indicated that the number of frog species present in the montane area (1200 – 3800 m)
has declined by approximately 36% from 1999 to 2008 and 2009, and is significantly
correlated with prevalence of Bd along the elevational gradient (Catenazzi et al., 2011).
Both G. nebulanastes and G. excubitor can be found near the Wayqecha Biological
Station (WBS) located at 2900 m on the mountainside of the valley. This research
station is just outside of Manu National Park in the region of Cusco. Its property
encompasses cloud forests, montane scrub forests, and grasslands from 2200 m to
3700 m. The Paucartambo-Shintuya Road runs through these ecosystems and provides
easy access.
Collection of frogs
Visual encounter surveys performed from May to July of 2014 recovered 36 G.
nebulanastes and 47 G. excubitor in the area surrounding WBS. Gastrotheca
nebulanastes were collected by walking along the Paucartambo-Shintuya Road at night,
where males were found calling from rocks and vegetation and juveniles were foraging.
No females were encountered during the sampling period. Previously recorded calls
were played to maximize the chance of locating calling males. Gastrotheca excubitor
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were collected during the day by searching under rocks, in bunchgrasses, and in moss
in the high-elevation grasslands they inhabit. Males, females and juveniles of this
species were all commonly encountered and therefore all were included in the sampling.
Frogs were collected by inverting a plastic bag over the collector’s hand, reducing
any risk of contamination from the collector’s skin (Robertson et al., 2013, Woodhams et
al., 2006a). A small piece of nearby vegetation, collected in the same manner, was
placed in each bag to provide moisture for the frog. Following a survey, all collected
frogs were brought back to WBS, stored in their individual bags in a cool location away
from direct sunlight, and sampled for peptides within 24 hours. Afterwards they were
released in the area at which they were found.
Sampling for Antimicrobial Peptides
Peptide secretion was stimulated by the injection of norepinephrine into each
frog’s dorsal lymph sack (Rollins-Smith et al., 2002c, Nutkins and Williams, 1989).
Norepinephrine injection provides a more standardized peptide collection technique
alternative to transdermal electrical stimulation, which requires calibration between
species and is thought to be more harmful (Tyler et al., 1992, Woodhams et al., 2006a).
Specifically, 0.1 ml of injection solution prepared as described below (Holden et al.,
2015) was administered per gram of frog body weight (Table 2). To obtain this
concentration in the field, pre-weighed quantities (0.675 mg) of norepinephrine were
combined with 5 ml of amphibian phosphate buffered saline (APBS, Table 2) and mixed
by vortex to produce a 40 nmol solution. This solution was then passed through a 0.22
m filter to sterilize it before use. A fresh batch of injection solution was made before
each AMP sampling.
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Prior to injection, the frog’s entire body was first rinsed for five seconds with
deionized water to remove any transient contaminants and dirt from its skin. The frog
was then placed into a sterile Whirl- Pak® bag (Nasco, Fort Atkinson, WI, USA) and
weighed to determine the volume of injection solution to administer. The frog was
manipulated to the top of the bag (without making contact with it) and the norepinephrine
solution was injected through the bag and into the frog’s dorsal lymph sack using a 1 mL
syringe with a new, sterile 5/8 inch 25 gauge needle for each frog. Immediately after
administering the injection solution, 25 ml of HPLC grade water was added to the bag as
a medium for peptide collection. The frog remained in the bag for 15 min, enough time to
allow the maximum amount of skin secretions to collect in the water before the peptides
may begin to degrade (Rollins-Smith et al., 2002c).
After 15 min, the frog was removed from the bag and 1 ml of 50% HCl (Table 2)
was added to the sample (Woodhams et al., 2006b) to inactivate any endogenous
peptidases that may be present (Resnick et al., 1991, Steinborner et al., 1997). The
samples were partially purified by passing them through Sep Pak cartridges (Waters
Corporation, Milford, MA, USA) (Goraya et al., 1998) that had previously been activated
by passing 10 mL of ethanol and then 10 mL of Buffer A (Table 2). Using a 60 mL
syringe, the entire volume of the collection water and skin secretions was collected from
the bag, pushed through a single Sep Pak cartridge at a rate of two drops per second
and collected in a waste container (Louise Rollins-Smith, pers. comm.). The cartridges
were then placed back in the Whirl-Pak® storage bags and kept with 2 mL of Buffer A to
stay moist until processing. Meanwhile, the frog was swabbed for Bd (see below),
measured for snout to vent length, and sexed.
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Elution of peptides from skin secretion samples
After collection, the skin secretion samples were transported to Vanderbilt
University and peptides were eluted from the Sep Pak cartridges by Laura Reinert in the
Rollins-Smith lab. Elution was achieved by passing the samples through a vacuum pump
set to 3 rpms. First, 10 mL of Buffer A were passed through the cartridges and into a
waste container to remove any unwanted material that may have been lodged in the
filter. Then, each cartridge was flushed with 11 mL of Buffer B, containing acetonitrile
which liberated the bound peptides. The resulting solution was collected in sterile,
individual 50 mL conical tubes. One mL from each sample was removed and placed into
a mini Eppendorf tube and stored at -80˚ C for peptide quantification (see below). The
remaining 10 mL of each sample was vacuum-centrifuged to dryness. The lyophilized
peptides were then re-suspended in HPLC water, each at a concentration of 1 mg/mL
(based on the quantity recovered per sample as determined by microBCA protein
assays, see description below) for composition analysis (Louise Rollins-Smith, pers.
comm.).
Quantifying peptides in skin secretion samples
Peptide concentrations per each sample were quantified using a Pierce
microBCA protein assay kit (Thermo Scientific, Rockford, Illinois). The assay tests 1:10
dilutions and non-diluted skin secretion samples against standards (200, 40, 20, 10, 5,
2.5, 1, and 0.5 µg/mL). The manufacturer’s protocol was followed, except the peptide
bradykinin (RPPGFSPFR) was used to determine the standards (Rollins-Smith et al.,
2002c, Smith et al., 1985). Solutions were plated on a 96-well plate with the standards

43

and blanks (Buffer B only) as negative controls, all in triplicate to increase the accuracy
of comparisons (Louise Rollins-Smith, pers. comm.). Next, the plate was incubated at
37˚C for two hours then cooled to room temperature for 10 minutes. The absorbance of
each well was analyzed using an absorbance microplate reader at 570 nm. The results
for each sample were compared with the standards to determine a peptide quantity per
sample. One juvenile G. excubitor sample was removed from analysis because it
contained no peptides.
Bd growth inhibition assays
Whole peptide mixtures were tested in vitro by dilution assays for their ability to
inhibit the growth of Bd zoospores (JEL 197, J. E. Longcore, University of Maine). Only
individual samples with enough peptide mixtures after resuspension (at least 600 µL at 1
mg/mL) to complete an assay were tested for growth inhibition (n= 9 for G. excubitor and
8 for G. nebulanastes). Bd was maintained at 19˚C in flasks with 1% tryptone broth
containing penicillin and streptomycin to inhibit bacterial growth. Only zoospores were
used because they are the infectious propagules of Bd (Rollins-Smith et al., 2002a).
Zoospore harvesting was initiated by first scraping the sides of flasks (containing at least
one week of growth, indicated by the presence of flakes of mature thalli) with a sterile
inoculation loop to remove any zoospores that were against the sides. Two mL of
solution was then removed from these flasks, flooded onto agar plates (tryptone, agar,
glucose), and dried under a laminar flow hood. These plates were then incubated at 1920˚C until swarms of active zoospores were visible, typically three to seven days.
Zoospores were harvested by flushing plates with tryptone broth and then passing the
liquid through a 20 µm filter in a Buckner Funnel attached to a vacuum flask. This filter
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size traps the mature thalli but allow zoospores to pass. The resulting zoospore-rich
broth was then transferred from the vacuum flask to a sterile 50-ml conical tube. A
sample of this solution, diluted in broth (1:10), was removed and placed onto a
hemocytometer to count zoospores. This value was used to dilute the original zoospore
rich solution to a concentration of 1x106 zoospores/ml.
The peptide-Bd inhibition assays were conducted on 96-well microtiter flat-bottom
plates, one plate per an individual frog’s peptide sample. Each well contained a total of
100 µL; the assay consisted of five replicates each of: positive controls for Bd growth
(50 µL zoospore solution and 50 µL HPLC water), negative controls for Bd growth (50
µL zoospore solution, placed in a 60 ˚C water bath for 10 min to heat kill zoospores, and
50 µL HPLC water), and peptide dilutions at 500, 250, 100, 50, 25, 12.5, 6.25, and 3.125
µg/mL of whole peptide mixtures (50 µL peptide solution and 50 µL zoospore solution).
Because plating of the assay resulted in diluting the zoospore solution 1:2, the final
concentration tested for growth inhibition was 5x105 zoospores/ml. The absorbance (A)
at 490 nm (A490) (Rollins-Smith et al., 2002c) was immediately recorded of each well
using a Fisher Scientific accuSkan GO UV/VIS microplate spectrophotometer (Fisher
Scientific, Hampton, NH, USA). Plates were then covered by a lid, sealed with Parafilm
(Bemis NA, Neenah, WA, USA), and incubated at 19-20˚C for seven days. On the
seventh day, the A490 was recorded again. Plates were regularly checked for
contamination by visual inspection, and any plates or wells that were contaminated were
excluded from analysis. Any assays with more than three excluded wells within a
treatment were removed from analysis.
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Peptide Composition analysis via MALDI TOF mass spectrometry
Peptide composition profiles were obtained for each individual frog sample (n= 36
for G. nebulanastes and 47 for G. excubitor) via matrix-assisted laser desorption
ionization (MALDI) time-of-flight (TOF) mass spectrometry (Woodhams et al., 2006b,
Rollins-Smith et al., 2006). Mass spectrometry was performed at SIUC on a Thermo
Scientific TraceGC PolarisQ Mass Spectrometer (Thermo Fisher Scientific, Waltham,
MA, USA) in linear mode. The instrument was calibrated using the following standards
(Sigma Aldrich, St. Louis, Missouri USA): bradykinin (m/z 904.468), angiotensin I (m/z
1296.685), Glu-Fibrinopeptide B (m/z 1570.677), ACTH 1-17 (m/z 2093.085), ACTH 1639 (m/z 2465.199), and insulin oxidized B chain (m/z 3494.6513). Combined standards
were mixed with matrix (10mg/mL α-cyano-4-hydroxycinnamic acid, 50% acetonitrile,
49.9% MilliQ water, 0.1% trifluoroacetic acid) at a ratio of 1:25 and peptide samples
were mixed with matrix at a ratio of 1:1. Both were spotted onto a MALDI plate,
alternating rows between samples and standards so that every sample spot was
adjacent to a standard spot.
Sampling for Bd
All individuals collected during the cutaneous peptide sampling were sampled for
the presence and quantification of Bd infection. For each frog, a sterile cotton swab was
streaked five times each on the side, between the front and rear limbs, the ventral pelvic
patch, the upper portion of each of the legs, and once on each interdigital membrane of
the hind feet (Hyatt et al., 2007). The swabs were immediately placed into individual
sterilized vials until processing by real time PCR. PrepMan Ultra was used to extract
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DNA from the swabs using the protocol outlined in Boyle et al. (2004) and Hyatt et al.
(2007), except extracts were analyzed once (Vredenburg et al., 2010). Real time PCR
was carried out on an Applied Biosystems StepOnePlus PCR machine to calculate the
genomic equivalent, ZE for Bd zoospores (henceforth “zoospores”). This method
quantifies these genomic equivalents by comparing each sample to a set of diluted
standards from 100 to 0.1 genomic equivalents of zoospores.
Statistical Analysis
All statistical analyses were completed using R version 3.0.3 (R Foundation).
Peptide amounts recovered were log transformed to meet the requirements of normality.
These values were then compared between species and sex and life stage (includes
males, females, and juveniles) using a two-way analysis of variance (ANOVA) with
Tukey’s post hoc test (n=3 for G. nebulanastes juveniles, 33 for G. nebulanastes males,
22 for G. excubitor juveniles, 12 for G. excubitor males, and 12 for G. excubitor
females). Additionally, the amounts of peptides were compared between sex and life
stage within G. excubitor (to look for differences among groups within a single species)
using a one way ANOVA with Tukey’s post hoc tests. This analysis was not done for G.
nebulanastes because, besides three juveniles, only males were sampled.
Data from inhibition assays were normally distributed (indicated by plotting
quantiles), thus outliers were removed from analysis after using Dixon’s Q test (Holden
et al., 2015). Positive control wells with no Bd growth and negative control wells with Bd
growth were also excluded from analysis. For each well, the A490 from the first day was
subtracted from that of the seventh day to determine A490. Mean A490 for the five
negative control wells was then subtracted from every well to account for any change in
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A490 not attributed to Bd growth. These resulting values were then taken as a
percentage of mean A490 for the positive control wells to standardize measurements
across assays for statistical comparisons. The resulting percentages (pA490)
represented Bd growth in each experimental well after the seven day period. pA490 < 1
represented Bd growth inhibition, while pA490 > 1 represented enhanced Bd growth.
The abilities for individual peptide mixtures to inhibit the growth of Bd were visualized
graphically by plotting the average percent of Bd growth for the different peptide
concentrations and the controls (Figures 6-7). For a peptide mixture to be considered
inhibitory it had to both significantly inhibit Bd growth at high concentrations and also
exhibit an overall negative correlation with Bd growth as concentration decreased.
Due to the design of the experiment, the amount of Bd growth among peptide
dilutions and between species was compared by a split plot ANOVA design (Figure 10).
The design treated individual frogs as a random effect nested within species and used
the average amount of growth (the average of the five replicates) for each concentration
within an individual. This design facilitated the statistical comparison of both frog species
and dilution as factors in a single analysis. The model was adjusted with a KenwardRoger Degrees of Freedom Approximation and paired with a Tukey’s post hoc test.
Peptide profiles generated by MALDI TOF mass spectrometry were analyzed
using the software Flex Analysis (Bruker, Billerica, MA, USA) to mark the masses in
Daltons (m/z) and intensities (counts per second) of peptide signals. The occurrence of
peptide signals were then compared among individuals between species and life
stage/sex, among individuals used for growth inhibition assays, and between individuals
that tested positive and negative for Bd. Only signals with strong intensities (>10% of the
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total intensity measured) and mass to charge ratios within the range of the standards
were included in the analysis. Signals within 2 Daltons were considered to be the same
peptide, and those that were 22 (+/- 2) Daltons greater were considered to be the
sodium adducts of the same peptide. Correlations between Bd inhibitory or enhancing
assayed samples and the presence of common peptide signals (shared by two or more
assayed samples) were determined using a one way ANOVA.

RESULTS

Amounts of peptides in skin secretion samples
Peptide amounts did not vary between G. nebulanastes and G. excubitor (Figure
2; df= 1, 77; p= 0.363), but amounts varied among life stages/sex (df=2,77 p<0.001) and
due to an interactive effect between species and life stage/sex (df=1,77 p=0.013).
Tukey’s post hoc test indicated that the amounts of peptides recovered were lower in G.
nebulanastes juveniles than in G. excubitor juveniles (df= 1,77 p= 0.011), G. excubitor
females (df=1,77 p< 0.001), G. excubitor males (df= 1,77 p< 0.001), and G.
nebulanastes males (df=1,77 p<0.001) (Figure 5). Within G. excubitor smaller peptide
amounts were recovered from juveniles than from males (df= 2,43 p=0.012) or females
(df=2,43 p=0.009).
Bd growth inhibition assays
Four out of the eight (50%) peptide samples from G. nebulanastes and five out of
the nine (56%) samples from G. excubitor inhibited Bd (Figures 6-9). Gastrotheca
species did not differ in their abilities to inhibit the growth of Bd (Figure 11, split-plot
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ANOVA, df=1,15 p=0.96), but there was a difference in concentration (df=7,105
p=0.046). There was no interaction between species and peptide concentration
(df=7,105 p=0.86). Inhibition was higher at 500 µg/mL than at 6.25 µg/mL (Tukey’s post
hoc test, df= 7,105 p=0.016).
Analysis via MALDI TOF mass spectrometry
The most common peptide signal shared between the two Gastrotheca species
had a mass to charge ratio of 1430 +/- 2 Daltons; also present was its sodium adduct at
1452 +/- 2 Daltons. This signal occurred in 59% (27 of the 46) of the G. excubitor
sampled, and in only one G. nebulanastes. Another frequent signal occurred at 1128 +/2 Daltons (Table 3). Interestingly, only G. excubitor expressed the peptide in this form
(n=6), but both species expressed the sodium adduct at 1150 +/- 2 Daltons (four G.
excubitor and nine G. nebulanastes). The frog species differed in the expression of
several peptides. Most notably only G. nebulanastes, but 53% of sampled individuals,
had a signal at 1688 +/- 2 Daltons. There was no correlation between peptide type and
Bd growth inhibition or enhancement, except for a peptide at 1298 +/- 2 Daltons found in
assayed G. excubitor samples. This peptide was correlated with Bd growth
enhancement (ANOVA, df=1,7 p=0.011).
Prevalence and intensity of Bd infection
Five out of 36 G. nebulanastes (14%, CI=5%-26%) and eight out of 46 G.
excubitor (17%, CI=8%-29%) tested positive for Bd. Infection levels varied from 0.14125.66 zoospores in G. nebulanastes and from 0.04-1223.23 zoospores in G. excubitor.
Of the assayed peptide samples, one came from an infected G. nebulanastes and one
50

came from an infected G. excubitor. This G. nebulanastes had a low infection level
(ZE=0.69 zoospores) and its peptides exhibited Bd growth enhancement. The G.
excubitor was the most infected individual (ZE=1223.23 zoospores) and its peptides
were relatively strong Bd growth inhibitors (70% maximum Bd growth at 500 µg/mL)
(Figure 8). There were no correlations between Bd infection and presence of peptide
signals.

DISCUSSION:
The peptides we analyzed, from the Bd-susceptible Gastrotheca nebulanastes
and the Bd-resistant G. excubitor, did not differ between species in quantity (Figure 5) or
in their abilities to inhibit the growth of Bd (Figure 11). However, there was considerable
variation among individuals, and some peptide samples exhibited patterns of growth
inhibition while some exhibited growth enhancement (Figures 6-9).
Peptide profiles failed to completely explain variation among individuals because
most peptide signals occurred in both inhibitory and enhancing peptide samples. Only
the peptide at 1298 +/- 2 Daltons showed correlation with Bd growth enhancement in
assayed G. excubitor samples. It is very likely that this peptide cannot inhibit Bd growth;
and perhaps it is responsible for enhancing it by providing nourishment for zoospores.
Although there were some shared peptide signals, overall each species produced
unique peptide profiles suggesting interspecific variation that is consistent with previous
research (Woodhams et al., 2007a, Rollins-Smith et al., 2006).
None of the assayed samples were able to completely inhibit Bd growth at any
concentration. Therefore, no MIC values were generated to compare with peptides
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analyzed by other studies. Interestingly, the peptide sample that demonstrated the most
growth inhibition, allowing only 57% Bd growth at 500 µg/mL, came from the susceptible
species, G. nebulanastes (Figure 6). Similarly, the susceptible Rana muscosa has been
shown to have more potent anti-Bd AMPs than resistant congenerics (Woodhams et al.,
2007b, Rollins-Smith et al., 2006). These results suggest that stronger peptides may be
necessary to provide in vivo protection. However, even peptides capable of complete
growth inhibition have been produced by susceptible frogs. This has been demonstrated
in frogs from different families distributed worldwide, including: Alytes obstetricans in
Europe (Bosch and Rincón, 2008), Silurana tropicalis in Africa (Parker et al., 2002),
Rana tarahuamara in the United States (Rollins-Smith et al., 2002c), and Hylomantis
lemur in South America (Conlon et al., 2007b).
It is difficult to attribute G. excubitor’s chytridiomycosis resistance to AMPs
because peptide samples from individuals within this species varied in their abilities to
inhibit Bd growth: some peptide mixtures inhibited Bd growth, but some enhanced it
(Figures 8 and 9). None of those that inhibited Bd growth were particularly strong
(Figure 8). One of the strongest inhibiting peptide mixture was collected from the frog
with the highest Bd load, suggesting that the Bd inhibition demonstrated by the assay
might not translate to in vivo inhibition.
The prevalence of Bd reported from this study was low and similar for the
Gastrotheca species. Historically, prevalence has been consistent for G. nebulanastes
but has varied for G. excubitor, although overall values were relatively low. No
individuals from either species tested positive for Bd in 2008 (Catenazzi et al., 2011). In
2009 prevalence was 25% and 18.2% (Catenazzi et al., 2011) and in 2012 prevalence
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was 25% and 46.4% (Burkart et al., unpublished) for G. nebulanastes and G. excubitor,
respectively. Despite the high prevalence for G. excubitor in 2012, individual infection
levels were generally low for both species (Burkart et al., unpublished). The overall low
prevalence of Bd infection observed between these species, despite their differences in
susceptibilities, may be attributed to their similar life history characteristics. Because
they are direct-developers (Duellman and Maness, 1980), it is unlikely that either utilizes
bodies of water, where Bd infection typically occurs. This may also explain why G.
nebulanastes coexists with Bd despite being susceptible to chytridiomycosis.
Perhaps the difference in susceptibility between these frogs can be attributed to
another defense mechanism such as anti-Bd skin bacteria. This defense has been
associated with chytridiomycosis resistance (Woodhams et al., 2007b, Becker and
Harris, 2010, Park et al., 2014). In a concurrent study we found that G. excubitor has
more and stronger anti-Bd skin bacteria than G. nebulanastes. Therefore, it is likely that
bacteria plays a more important role in protecting G. excubitor from Bd than AMPs.

CONCLUSIONS:
Understanding what protects resistant frog species from chytridiomycosis can
assist in the development of mitigation strategies. Our results suggest that, at least for
these marsupial frogs, peptides are not important contributors to chytridiomycosis
resistance. Perhaps other defenses like cutaneous bacteria are. So far there has been
some progress made towards developing a bioaugmentation strategy using probiotic
bacteria to protect susceptible frogs. Although this method is still in development, it has
been implemented successfully in vitro, and there are currently no proposals to use
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AMPs as a mitigation strategy. However, it will be important to continue exploring the
anti-Bd abilities of both of these defenses. Both skin bacteria and AMPs coexist in the
microbiome of the skin, and it is likely that interactions between the two dictate their antiBd abilities in vivo.
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Table 2: Solutions used for AMP collection.
____________________________________________________________________
Solution

Purpose

Ingredients

Reference

Norepinephrine Injection Stimulate the
(40 nmol norepinephrine) release of AMPs

Norepinephrine, APBS

Rollins-Smith
et al. 2005

Amphibian Phosphate
Buffered Saline (APBS)

6.6 g of NaCl, 1.15 g
of anhydrous Na2HPO4,

Doug
Woodhams,

0.2 g of KH2PO4, per 1
liter of ultra-pure (HPLC
grade) water

pers. comm.

550 ml of concentrated
HCl, 500 ml HPLC water

Doug
Woodhams,
pers. comm.

Solvent for
norepinephrine

50% HCl buffer

Acidify skin
washings

Buffer A (0.1% HCl)

Activating Sep Pak 1 ml of concentrated HCl, Doug
cartridges
1 liter of HPLC water
Woodhams,
pers. comm.

Buffer B (70% acetonitrile) Elution of peptides 700 ml of acetonitrile,
Louise
Rollins
from Sep Pak
1 ml of concentrated HCl, Smith, pers.
cartridges
and 300 ml of HPLC
comm.
grade water
______________________________________________________________________________________
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Table 3: Numbers of Gastrotheca individuals with common peptide signals. The top row
is G. nebulanastes and the bottom G. excubitor.
______________________________________________________________________
Peptide m/z
1128/1150 1226 1298 1430/1452 1437

1688

1911

2160 2164 3164 3742

6/4

0

6

22/5

0

0

5

5

4

0

5

0/9

9

3

1/0

5

19

0

0

0

7

0

______________________________________________________________________________________
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Figure 5: Mean, quartiles, and range of peptide mixture amounts recovered for all
individuals (dots indicate outliers).
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Figure 6: Mean +

490,

as a function of peptide mixture

concentration (500-3.125 µg/mL), for peptide mixtures of G. nebulanastes that inhibited
Bd. N indicates negative control and P positive control. Each panel (A-D) represents the
results from an indivual peptide sample.
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Figure 7:

490

(mean + SE), as a function of peptide mixture

concentration (500-3.125 µg/mL), for samples from G. nebulanastes that did not inhibit
Bd. N indicates negative control and P positive control. Each panel (A-D) represents the
result from an individual peptide sample.
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Figure 8: Mean +

490,

as a function of peptide mixture

concentration (500-3.125 µg/mL), for peptide mixtures of G. excubitor that inhibited Bd.
N indicates negative control and P positive control. Each panel (A-E) represents the
results from an indivual peptide sample.
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Figure 9: Mean +

490,

as a function of peptide mixture

concentration (500-3.125 µg/mL), for peptide mixtures of G. excubitor that did not inhibit
Bd. N indicates negative control and P positive control. Each panel (A-D) represents the
results from an indivual peptide sample.
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Figure 10: The split plot design of the Bd growth inhibition assays. Level 1 is species,
Level 2 individuals sampled (n=8 for G. nebulanastes and n=9 for G. excubitor), and
Level 3 are the different peptide concentrations tested. There were five replicates of
every concentration for each individual, but replicates were average for analysis.
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Figure 11: Growth for each sample assayed (mean of the five replicates) per peptide
concentration. Blue indicates values for G. nebulanastes and orange values for G.
excubitor.
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